| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/18/2000 | US6051554 Cyclized peptides |
| 04/18/2000 | US6051553 Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products |
| 04/18/2000 | US6051551 Antidiabetic agents; hypoglycemic agents; inhalationadministering |
| 04/18/2000 | US6051550 Materials and methods for controlling homopteran pests |
| 04/18/2000 | US6051549 Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof |
| 04/18/2000 | US6051430 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 04/18/2000 | US6051429 Peptide-enhanced cationic lipid transfections |
| 04/18/2000 | US6051427 Retroviral packaging plasmid including retroviral helper dna lacking native enhancer and/or promoter of the viral 5' long terminal repeat, the psi function sequence and the 3' long terminal repeat, but encodes foreign regulatory sequences |
| 04/18/2000 | US6051426 Vector includes dna sequences encoding pre-s and s region of hepatitis b genome under control of heterologous promoter; for use in chinese hamster ovary cells to produce vaccines having immunogenic properties of hepatitis b surface antigen |
| 04/18/2000 | US6051424 Human cDNAs and proteins encoded thereby |
| 04/18/2000 | US6051419 Genes which influence pichia proteolytic activity, and uses therefor |
| 04/18/2000 | US6051418 Hybrid proteins with modified activity |
| 04/18/2000 | US6051415 Methods and kits for stimulating production of megakaryocytes and thrombocytes |
| 04/18/2000 | US6051410 Self-assembled, defective, nonself-propagating viral particles |
| 04/18/2000 | US6051406 Keratan sulfate 6-sulfotransferase and DNA coding for the same |
| 04/18/2000 | US6051405 An expression vector containing a dna segment that directs the synthesis of a recombinant fusion protein which is a single chain fab variable region from a modified pseudomonas exotoxin gene; producing improved toxins |
| 04/18/2000 | US6051404 A nucleic acid encoding a protein; vaccines for poultry |
| 04/18/2000 | US6051403 A dna molecule encoding a polypeptide having homology to sh2 domains as determined by blast-2 sequence alignment computer program; modulating intracellular signaling pathways |
| 04/18/2000 | US6051402 A nucleic acid encoding an anti-sickling beta-globin protein; gene therapy for sickle cell |
| 04/18/2000 | US6051401 Methods and constructs for protein expression |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051399 Production of C-terminal amidated peptides from recombinant protein constructs |
| 04/18/2000 | US6051398 Nucleic acids encoding CR3 polypeptide, vector and transformed cell thereof, and expression thereof |
| 04/18/2000 | US6051397 DNA encoding MCK-10, a novel receptor tyrosine kinase |
| 04/18/2000 | US6051396 Method for producing retinoblastoma gene protein products |
| 04/18/2000 | US6051386 Introducing a stimulant to test cells of a pigment cell line expressing exogenous cell surface receptor to set an initial state of pigment disposition, contacting with test chemical; change in pigment disposition indicates an agonist |
| 04/18/2000 | US6051385 Compositions and methods for identifying and testing therapeutics against HSV infection |
| 04/18/2000 | US6051384 Method of detecting p53-specific antibodies |
| 04/18/2000 | US6051383 Protein from pseudomonas fluorescens involved in antibiotic biosynthesis; for transformed bacteria that are useful as agricultural biocontrol agents against fungal pathogens |
| 04/18/2000 | US6051376 Uses of mda-6 |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051374 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
| 04/18/2000 | US6051373 Methods for screening for inhibitors of the transcription-enhancing activity of the X protein of hepatitis B virus |
| 04/18/2000 | US6051372 Imprinted amphiphilic molecules having hydrophobic tail groups and hydrophilic head groups forming three-dimensional molecular imprinted surface at solid/liquid interface; for molecular separation, isolation, purification or catalyzation |
| 04/18/2000 | US6051240 Separating culture into cells and supernatant; concentrating supernatant; contacting with calcium ions in presence of phosphate ions to form calcium phosphate gel; separating gel to recover supernatant; contacting with ion exchange gel |
| 04/18/2000 | US6051239 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/18/2000 | US6051237 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 04/18/2000 | US6051232 Comprising allogenic chimeric major histocompatibility complex class i milecule; to induce tolerance to donor grafts when administered to the recipient at time of transplantation |
| 04/18/2000 | US6051231 Antiviral methods and prepations |
| 04/18/2000 | US6051228 Antibodies against human CD40 |
| 04/18/2000 | US6051227 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 04/18/2000 | US6051226 use of antibodies targeting the MN oncoprotein conjugated to an anticancer therapeutic agent such as drug or toxin for tissue targeted cancer therapy |
| 04/18/2000 | US6051224 Compositions and methods for targeting cells and modulating pulmonary surfactant secretion |
| 04/18/2000 | US6051222 Cancer diagnosis; genetic engineering |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/18/2000 | CA2192184C Extraction of heterologous insoluble proteins from bacteria |
| 04/18/2000 | CA2132742C Synthetic peptides and vaccines against parvovirus |
| 04/18/2000 | CA2092195C Retroviral packaging cell line |
| 04/18/2000 | CA2071956C Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor |
| 04/18/2000 | CA1340964C Crf analogs |
| 04/18/2000 | CA1340963C Gene for encoding a human malaria vaccine antigen |
| 04/16/2000 | CA2284857A1 G protein coupled receptor a4 |
| 04/13/2000 | WO2000020867A1 A novel ret-independent signaling pathway for gdnf |
| 04/13/2000 | WO2000020835A2 Thromboplastin reagents and methods for preparing and using such reagents |
| 04/13/2000 | WO2000020638A2 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 04/13/2000 | WO2000020627A1 Use of ynes, essential bacterial genes and polypeptides |
| 04/13/2000 | WO2000020624A1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect |
| 04/13/2000 | WO2000020622A1 Zinc finger peptide cleavage of nucleic acids |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020617A1 Intercellular propagation of recombinant dna |
| 04/13/2000 | WO2000020616A1 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(XANTHOMONAS CAMPESTRIS) |
| 04/13/2000 | WO2000020614A1 Geminivirus resistant transgenic plants |
| 04/13/2000 | WO2000020612A2 Therapeutically active proteins in plants |
| 04/13/2000 | WO2000020609A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 04/13/2000 | WO2000020607A2 Chimaeric proteins between members of tgf-beta superfamily |
| 04/13/2000 | WO2000020606A1 Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus |
| 04/13/2000 | WO2000020600A1 Avian pneumovirus vaccine and diagnostic agent |
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020597A1 Novel strains of the bacillus subtilis group for food fermentation |
| 04/13/2000 | WO2000020596A1 Fungal transcriptional activator useful in methods for producing polypeptides |
| 04/13/2000 | WO2000020595A1 Interleukin-1 homolog |
| 04/13/2000 | WO2000020594A1 Tsg-5: a tnf-inducible gene |
| 04/13/2000 | WO2000020593A1 Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and uses thereof |
| 04/13/2000 | WO2000020592A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020590A2 G-protein coupled receptor proteins |
| 04/13/2000 | WO2000020589A2 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |
| 04/13/2000 | WO2000020588A2 Bone marrow-derived serum proteins |
| 04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020586A2 Renal cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020585A1 Mammalian timeless and methods of use thereof |
| 04/13/2000 | WO2000020584A2 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 04/13/2000 | WO2000020583A1 Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptor |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020580A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/13/2000 | WO2000020579A1 Spliced form of erbb-2/neu oncogene |
| 04/13/2000 | WO2000020578A1 A method of modulating cell survival and reagents useful for same |
| 04/13/2000 | WO2000020577A1 Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth |
| 04/13/2000 | WO2000020576A2 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
| 04/13/2000 | WO2000020575A1 Pollinosis-associated gene |
| 04/13/2000 | WO2000020574A2 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | WO2000020571A2 Maize promoters |
| 04/13/2000 | WO2000020570A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/13/2000 | WO2000020566A2 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
| 04/13/2000 | WO2000020562A1 A novel lymphocyte population expressing intracellular mo2 |
| 04/13/2000 | WO2000020561A1 Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using |
| 04/13/2000 | WO2000020559A1 Method for the treatment of chemonucleolysis |
| 04/13/2000 | WO2000020459A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use |
| 04/13/2000 | WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |